FDA’s Spring Regulatory Agenda Includes 17 Rx Drug-Related Rules / FDA’s prescription drug regulations in the works include rules on generic drug labeling, compounding, bioequivalence reports and safety reporting for combination products. / “The Pink Sheet” June 2 2014 12:01 AM
No comments:
Post a Comment